Navigation Links
Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time
Date:3/19/2009

March 19, 2009 (BRONX, NY) Researchers from the Albert Einstein College of Medicine and The University of Pittsburgh have developed an onsite method to quickly diagnose tuberculosis (TB) and expose the deadly drug-resistant strains that can mingle undetected with treatable TB strains. This study will be published in PLoS ONE, a peer-reviewed online journal from the Public Library of Science.

The researchers engineered bacteriophages, tiny viruses that attack bacteria, with a green fluorescence protein (GFP) implanted in their genome. Bacteriophages spread by injecting their DNA into bacterial cells. In this case, the GFP gene accompanies the DNA of the phage into the Mycobacterium tuberculosis cell, the bacterium that causes TB, causing the cell to glow. A clinician could detect the glow with equipment available at many clinics.

"The development of these reporter flurophages allows us to bypass the existing method of diagnosing TB, which requires cultivating slow-growing bacteria in a biosafety level 3 environment, a time-consuming and costly process," says William R. Jacobs, Jr., Ph.D., one of the authors of the study. "By infecting live M. tuberculosis cells with a flurophage, a quick and highly sensitive visual reading can be done. We are optimistic that we can move the diagnostic process from several weeks to several days or even hours, which could have a significant impact on treatment."

"A report from South Africa showed that the extensively drug-resistant TB strains can kill within 16 days, on average," says Graham Hatfull, Ph.D., the lead author and close collaborator of Dr. Jacobs. "In rural Africa, it takes too long to collect samples, send them off, do the test, and have the data sent back. Clinicians need rapid, relatively cheap, and simple methods for detecting TB and drug-resistant strains in the local clinic. This test provides a quick diagnosis so the patient can be isolated and treated."

Besides quick diagnosis, the test also could be used to distinguish treatable TB strains from those that are drug resistant (DR-TB) and extensively drug resistant (XDR-TB), which normally takes months. Researchers treated M. tuberculosis with antibiotics at the same time the bacteriophages were introduced; the TB strains that were sensitive to antibiotics died, but the drug-resistant cells survived and continued to glow.

The study, "Fluoromycobacteriophages for Rapid, Specific, and Sensitive Antibiotic Susceptibility Testing of Mycobacterium tuberculosis," will appear in the March 19, 2009 edition of PLoS ONE.

The group's research was funded as part of a major new research initiative from Howard Hughes Medical Institute (HHMI). HHMI announced on March 19 that it will partner with University of KwaZulu-Natal in South Africa to establish an international research center focused on the TB and HIV coepidemics, called KwaZulu-Natal Research Institute for TB-HIV (K-RITH). Dr. Jacobs will direct research into developing rapid and effective TB tests, one of the new institute's primary objectives. His work with Hatfull and postdoctoral fellow Mariana Piuri on the flurophage study was related to that effort.


'/>"/>

Contact: Deirdre Branley
dbranley@aecom.yu.edu
718-430-2923
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Empire State Stem Cell Board awards $12.7 million to Albert Einstein College of Medicine
2. Einstein scientists receive $10 million NIH grant
3. Einstein researchers develop technique to count messages made by single genes
4. Einstein researchers develop a new way to study how breast cancer spreads
5. In scientific first, Einstein researchers correct decline in organ function associated with old age
6. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
7. Einstein researchers receive grants totaling $700,000 for innovative breast cancer research
8. Einstein researcher receives NIH grant to explore epigenetic regulation of the human genome
9. University researchers to develop coatings that kill superbugs
10. K-State researchers work with university in Ghana to create biofuels from native tree seeds
11. Heinz Maier-Leibnitz Prizes 2009: Six young researchers recognized for outstanding achievements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... LIVERMORE, Calif. , March 21, 2017 ... recognition analytics company serving law enforcement agencies, announced today ... Sheridan as director of public safety business development. ... of diversified law enforcement experience, including a focus on ... Vigilant. In his most recent position, Mr. Sheridan served ...
(Date:3/13/2017)... of security: Biometric Face Matching software  Continue Reading ... ... match face pictures against each other or against large databases. The recognition of ... ... for biometric Face Matching on the market. The speed is at 100 million ...
(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... ... March 22, 2017 , ... March 22, 2017...Council for Agricultural ... green revolution, one that utilizes technological innovation in smart, sustainable ways. Humans depend on ... such as aesthetics and environmental stability. This paper is the first in a series ...
(Date:3/22/2017)... 22, 2017  Personal Genome Diagnostics Inc. (PGDx) ... contract with the U.S. Department of Veterans Affairs ... with the company,s new CancerSELECT ™ 125 ... pan-cancer profiling test that includes microsatellite instability status ... response to checkpoint inhibitor immunotherapies. CancerSELECT 125 will ...
(Date:3/22/2017)... 22, 2017   Invitae Corporation (NYSE: ... companies, today announced the availability of a new ... Muscular Atrophy (SMA) , a neuromuscular disease that ... among infants as well as a significant cause ... test, announced during the American College of Medical ...
(Date:3/20/2017)... Diego, CA (PRWEB) , ... ... ... (EDCs) are substances that interfere with the ability of endogenous hormones to ... or inhibiting ligand binding activity (antagonists), EDCs produce adverse reproductive, neurological, proliferative, ...
Breaking Biology Technology: